↓ Skip to main content

Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS

Overview of attention for article published in Cochrane database of systematic reviews, March 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter
1 tweeter
f1000
1 research highlight platform

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS
Published in
Cochrane database of systematic reviews, March 2013
DOI 10.1002/14651858.cd005481.pub3
Pubmed ID
Authors

Muki S Shey, Eugene J Kongnyuy, Samuel M Alobwede, Charles S Wiysonge

Abstract

UNAIDS estimates that 34 million people are currently living with the human immunodeficiency virus (HIV) worldwide. Currently recommended regimens for initiating HIV treatment consist of either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or ritonavir-boosted protease inhibitor (PI) combined with two nucleoside reverse transcriptase inhibitors (NRTIs). However, there may be some patients for whom NNRTIs and PIs may not be appropriate. This is an update of the review published in the Cochrane Library Issue 3, 2009.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Brazil 1 1%
Unknown 77 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 20%
Researcher 14 18%
Student > Bachelor 10 13%
Student > Ph. D. Student 9 11%
Student > Doctoral Student 4 5%
Other 13 16%
Unknown 13 16%
Readers by discipline Count As %
Medicine and Dentistry 32 41%
Social Sciences 10 13%
Nursing and Health Professions 5 6%
Psychology 5 6%
Agricultural and Biological Sciences 3 4%
Other 11 14%
Unknown 13 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2016.
All research outputs
#7,230,406
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#7,410
of 8,923 outputs
Outputs of similar age
#69,580
of 152,312 outputs
Outputs of similar age from Cochrane database of systematic reviews
#83
of 119 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,312 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.